| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |